
- Headquarters
- Sydney
- Employees
- 1–10
- Founded
- 2017
- Business Model
- B2B
- Website
- baymatob.com
- Total Funding
- $14.3M
- Last Round
- $6.5M Series AMay 2026
- Rounds
- 5
About
Baymatob develops Oli, a wireless wearable maternal and fetal monitoring platform powered by AI. Oli captures physiological data via ten biosensors to identify postpartum hemorrhage risk before birth. The device has received FDA Breakthrough Device Designation.
Summary
Baymatob is a Femtech company based in Sydney, Australia, founded in 2017. It has raised $14.3M in total across 5 rounds, most recently a $6.5M Series A round in May 2026. Investors include Scale Investors.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
May 2026
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies

Healthcare AI platform that converts patient-clinician conversations into structured clinical not...

OpenEvidence is an AI copilot for doctors that helps them make high stakes decisions at the point...

Clinical-stage medical technology company developing neural-engineering implants and platforms to...

Largest national, virtual, in-network psychiatry practice
Flo Health is an all-in-one women's health app working to support users at every stage of their h...
Implantable neuromodulation device targeting the vagus nerve to treat chronic inflammatory diseas...